Back to NBIX
Creative Planning NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
8
Latest value
$10.9M
Q3 2026
Peak value
$12.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $17K |
| Q3 2025 | $4.5M |
| Q4 2025 | $7.6M |
| Q1 2026 | $9M |
| Q2 2026 | $28K |
| Q2 2026 | $12.9M |
| Q3 2026 | $40K |
| Q3 2026 | $10.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $10.9M | 76.9K | — | — |
| Q3 2026 | $40K | 281 | — | — |
| Q2 2026 | $12.9M | 76.7K | — | — |
| Q2 2026 | $28K | 166 | — | — |
| Q1 2026 | $9M | 68.4K | — | — |
| Q4 2025 | $7.6M | 53.3K | — | — |
| Q3 2025 | $4.5M | 32.3K | — | — |
| Q3 2025 | $17K | 122 | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M